Expression and localization of the CDC34 ubiquitin-conjugating enzyme in pediatric acute lymphoblastic leukemia.

Ubiquitin-dependent protein degradation impacts many cellular processes.However, the regulation of ubiquitin-conjugating enzymes (UBCs) in cancer is unknown. We find that the human CDC34 UBC protein is expressed at a 3-4 fold higher level (P < 0.001) in pediatric T cell than in pre-B-cell acute lymphoblastic leukemia (ALL) before treatment in two independent patient sets. The level of CDC34 mRNA was similar in both types of leukemia. CDC34 expression levels in normal resting T cells, B cells and activated T lymphocytes was comparable with pre-B-cell ALL. CDC34 protein (but not mRNA) was also increased in T-cell ALL compared with pre-B-cell ALL cell lines. The difference in expression was not attributable to mutation or associated with altered CDC34 stability. Immunohistochemistry and cellular fractionation reveals a heterogeneous CDC34 expression pattern including cells containing primarily cytoplasmic or nuclear protein. Thus, a feature of pediatric T-cell ALL is posttranscriptional up-regulation and heterogeneous localization of the human CDC34 UBC.

[1]  M. Kirschner,et al.  Proteolysis and DNA replication: the CDC34 requirement in the Xenopus egg cell cycle. , 1997, Science.

[2]  J. Moroianu,et al.  Nuclear import and export pathways , 1999, Journal of cellular biochemistry.

[3]  M. Pagano,et al.  Cell cycle regulation by the ubiquitin pathway , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  R. Deshaies.  SCF and Cullin/Ring H2-based ubiquitin ligases. , 1999, Annual review of cell and developmental biology.

[5]  L. Chuang,et al.  Regulation of Nuclear Transport and Degradation of the Xenopus Cyclin-dependent Kinase Inhibitor, p27Xic1 * , 2001, The Journal of Biological Chemistry.

[6]  M. Goebl,et al.  An Essential Domain within Cdc34p Is Required for Binding to a Complex Containing Cdc4p and Cdc53p in Saccharomyces cerevisiae * , 1998, The Journal of Biological Chemistry.

[7]  P. Beer-Romero,et al.  Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. , 1995, Science.

[8]  M. Gstaiger,et al.  Association of human CUL‐1 and ubiquitin‐conjugating enzyme CDC34 with the F‐box protein p45SKP2: evidence for evolutionary conservation in the subunit composition of the CDC34–SCF pathway , 1998, The EMBO journal.

[9]  S. Plon,et al.  Human Cdc34 and Rad6B Ubiquitin-Conjugating Enzymes Target Repressors of Cyclic AMP-Induced Transcription for Proteolysis , 1999, Molecular and Cellular Biology.

[10]  W. Krek,et al.  Association of human ubiquitin-conjugating enzyme CDC34 with the mitotic spindle in anaphase. , 2000, Journal of cell science.

[11]  F. Behm,et al.  Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy , 1990 .

[12]  R. Deshaies.  Phosphorylation and proteolysis: partners in the regulation of cell division in budding yeast. , 1997, Current opinion in genetics & development.

[13]  M. Oren,et al.  Mdm2 promotes the rapid degradation of p53 , 1997, Nature.

[14]  L. Hengst,et al.  Translational Control of p27Kip1 Accumulation During the Cell Cycle , 1996, Science.

[15]  M. Groudine,et al.  Cloning of the human homolog of the CDC34 cell cycle gene by complementation in yeast. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[16]  A. Harris,et al.  The ubiquitin-proteasome pathway in cancer. , 1998, British Journal of Cancer.

[17]  M. Karin,et al.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. , 2000, Annual review of immunology.

[18]  M. Künzler,et al.  Yeast Ran-binding Protein Yrb1p Is Required for Efficient Proteolysis of Cell Cycle Regulatory Proteins Pds1p and Sic1p* , 2000, The Journal of Biological Chemistry.

[19]  Kim Nasmyth,et al.  The B-type cyclin kinase inhibitor p40 SIC1 controls the G1 to S transition in S. cerevisiae , 1994, Cell.

[20]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.